Bortezomib Booms For Stada As Russian Problem Remains

Turnaround Strategy Is In The Works In Russia

 
• By Dean Rudge
  
Rock_Climber_Greece
Stada's sales climbed by 12% in 2019 following the bortezomib launch • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business